BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) Institutional Ownership Changes & 13F Activity

BRIDGEBIO ONCOLOGY THERAPEUT (BBOT). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Cormorant Asset Management, Lp, Deerfield Management Company, L.P., Omega Fund Management, Llc, Wellington Management Group Llp, and Ecor1 Capital, Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Ikarian Capital, LlcBuy+220,231—220,231$2.76MQ4 2025Feb 18, 2026
Cormorant Asset Management, LpBuy+17,878,594—17,878,594$223.84MQ4 2025Feb 17, 2026
Deerfield Management Company, L.P.Buy+4,885,446—4,885,446$61.17MQ4 2025Feb 17, 2026
Omega Fund Management, LlcBuy+3,289,661—3,289,661$41.19MQ4 2025Feb 17, 2026
Wellington Management Group LlpBuy+2,907,003—2,907,003$36.40MQ4 2025Feb 17, 2026
Ecor1 Capital, LlcBuy+2,823,126—2,823,126$35.35MQ4 2025Feb 17, 2026
Enavate Sciences Gp, LlcBuy+2,626,946—2,626,946$32.89MQ4 2025Feb 17, 2026
Citadel Advisors LlcBuy+2,530,324—2,530,324$31.68MQ4 2025Feb 17, 2026
Paradigm Biocapital Advisors LpBuy+2,261,749—2,261,749$28.32MQ4 2025Feb 17, 2026
Novo Holdings A/SBuy+1,961,317—1,961,317$24.56MQ4 2025Feb 17, 2026
Adage Capital Partners Gp, L.L.C.Buy+1,400,000—1,400,000$17.53MQ4 2025Feb 17, 2026
Octagon Capital Advisors LpBuy+1,043,110—1,043,110$13.06MQ4 2025Feb 17, 2026
Armistice Capital, LlcBuy+1,000,000—1,000,000$12.52MQ4 2025Feb 17, 2026
Price T Rowe Associates IncBuy+803,134—803,134$10.06MQ4 2025Feb 17, 2026
Casdin Capital, LlcBuy+282,312—282,312$3.53MQ4 2025Feb 17, 2026
Millennium Management LlcBuy+241,415—241,415$3.02MQ4 2025Feb 17, 2026
Fmr LlcBuy+240,300—240,300$3.01MQ4 2025Feb 17, 2026
Highvista Strategies LlcBuy+229,263—229,263$2.87MQ4 2025Feb 17, 2026
Adar1 Capital Management, LlcBuy+226,248—226,248$2.83MQ4 2025Feb 17, 2026
Sio Capital Management, LlcBuy+130,628—130,628$1.64MQ4 2025Feb 17, 2026
Woodline Partners LpBuy+103,707—103,707$1.30MQ4 2025Feb 17, 2026
Moore Capital Management, LpBuy+100,000—100,000$1.25MQ4 2025Feb 17, 2026
Stempoint Capital LpBuy+86,517—86,517$1.08MQ4 2025Feb 17, 2026
Boothbay Fund Management, LlcBuy+67,034—67,034$839.27KQ4 2025Feb 17, 2026
Northern Trust CorpBuy+58,034—58,034$726.59KQ4 2025Feb 17, 2026
Qube Research & Technologies LtdBuy+35,952—35,952$450.12KQ4 2025Feb 17, 2026
Xtx Topco LtdBuy+28,633—28,633$358.49KQ4 2025Feb 17, 2026
Point72 Asset Management, L.P.Buy+23,584—23,584$295.27KQ4 2025Feb 17, 2026
Quadrature Capital LtdBuy+12,922—12,922$161.78KQ4 2025Feb 17, 2026
Persistent Asset Partners LtdBuy+8,585—8,585$107.48KQ4 2025Feb 17, 2026
Showing 30 of 50

Frequently asked questions about BBOT activity

  • Which institutional owners are buying BBOT?

    Institutional owners buying BBOT include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in BBOT activity?

    "Buy" means an investor increased their reported position in BBOT compared to the prior reporting period. This reflects growing exposure to BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in BBOT increasing?

    Institutional interest in BBOT can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

BBOT Institutional Ownership Changes and 13F Activity Q4 2025 | InsiderSet